Monday 21 April 2014

RheumShorts: Methotrexate, Basiliximab, and Norwegian Lyme (CME/CE)

(MedPage Today) -- Subcutaneous methotrexate can be given at higher doses than in the oral route, while maintaing bioavailability, which could make for better tolerance and better adherence to treatment guidelines, a new study suggested. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment